Onconetix Inc (ONCO) News & EventsONCOOnconetix Inc

Realbotix Updates Nasdaq Reverse Takeover Transaction

Realbotix (XBOTF) provided an update on its previously announced transaction to list Realbotix LLC on the Nasdaq Capital Market via a reverse takeover transaction with Onconetix (ONCO). The proposed transaction will result in the robotics and AI business of RealLLC to be listed on Nasdaq, with the Parent Company maintaining a 75-90% ownership stake. No action is required by existing Realbotix shareholders as there are no changes to the structure of the Parent Company. The transaction is expected to close by October 2026. Realbotix shareholders retain the upside potential of the enterprise robotics and AI business within RealLLC. There are no shares being issued by the Parent Company nor is a share consolidation required in the proposed transaction. Realbotix will appoint four out of five directors to the ONCO board of directors at close. This transaction unlocks value in the commercial robotics and AI business held at RealLLC by separating it from the Parent Company's direct-to-consumer business. The closing capital at ONCO provides non-dilutive financing to grow the commercial robotics and AI business. RealLLC is a Nevada based subsidiary of Realbotix, the Parent Company. RealLLC designs and manufactures AI-powered humanoid robots for use in consumer-facing social roles such as customer service, healthcare, education, hospitality, and entertainment. RealLLC's operations include an engineering division, AI software division, robotics patents, and intellectual property. The proposed transaction, first announced on February 12, 2026, remains subject to certain conditions precedent to closing, including the requisite approval of the ONCO shareholders and regulators.

Onconetix Files to Sell 25M Shares of Common Stock

Onconetix files to sell 25M shares of common stock for holders